Gilstrap Says AstraZeneca Rival Had No Undue Delay In IP Suit
U.S. District Judge Rodney Gilstrap has made another ruling on the issue of whether a patent was prosecuted poorly enough to merit undoing an infringement verdict, in this instance rejecting AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article